Non-tuberculous mycobacterial infections in the Scottish borders: Identification, management and treatment outcomes - A retrospective review

Journal of the Royal College of Physicians of Edinburgh

Volumn 41, Issue 4, 2011, Pages 294-303

  McCallum, A D ^a   Watkin, S W ^a   Faccenda, J F ^a  

^a BORDERS GENERAL HOSPITAL   (United Kingdom)

Author keywords

BTS guidelines; Epidemiology; Non tuberculous mycobacteria

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; MOXIFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DIARRHEA; DRUG TREATMENT FAILURE; HUMAN; MEDICAL AUDIT; MEDICAL SOCIETY; MORBIDITY; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM NONCHROMOGENICUM; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TERRAE; MYCOBACTERIUM XENOPEI; NAUSEA; NON TUBERCULOUS MYCOBACTERIAL INFECTION; NONHUMAN; PRACTICE GUIDELINE; RELAPSE; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; UNITED KINGDOM; VOMITING;

ANTI-INFECTIVE AGENTS; GUIDELINE ADHERENCE; HUMANS; LUNG DISEASES; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INFECTIONS; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY TRACT DISEASES; SCOTLAND; STATE MEDICINE; TREATMENT OUTCOME;

EID: 83455206181     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: 10.4997/JRCPE.2011.403     Document Type: Review

References (33)

1. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunistic mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000; 55:210-218. http://dx.doi.org/10.1136/thorax.55.3.210
2. Griffith DE, Aksamit T, Brown-Elliot BA et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416. http://dx.doi.org/10.1164/rccm.200604-571ST
3. Marras TK, Chedore P, Ying AM et al. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007; 62:661-666. http://dx.doi.org/10.1136/thx.2006.070797
4. Patel JB, Leonard DGB, Pan X et al. Sequence-based identification of Mycobacterium species using the MicroSeq 500 16S rDNA Bacterial Identification System. J Clin Microbiol 2000; 38:246-251.
5. Johnson MM, Waller EA, Leventhal JP. Non-tuberculous mycobacterial pulmonary disease. Curr Opin Pulm Med 2008; 14:203-210. http://dx.doi.org/10.1097/MCP.0b013e3282f9e650
6. Bange FC, Brown BA, Smaczny C et al. Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clin Infect Dis 2001; 32:1648-1650. http://dx.doi.org/10.1086/320525
7. Kobashi Y, Yoshida K, Niki Y et al. Sibling cases of mycobacterium avium complex disease associated with hematological disease. J Infect Chemother 2006; 12:331-334. http://dx.doi.org/10.1007/s10156-006-0461-z
8. Olivier KN, Weber DJ, Wallace RJ Jr et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003; 167:828-834. http://dx.doi.org/10.1164/rccm.200207-678OC
9. Leber A, Marras TK. The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada. Eur Respir J 2010; 37:1158-1165. http://dx.doi.org/10.1183/09031936.00055010
10. General Register Office for Scotland [Internet]. Comparative population profile: Borders Health Board Scotland [cited 2010 Dec 18]. Available from: http://www.scrol.gov.uk/scrol/browser/profile.jsp?profile=Population&mainLevel=HealthBoard&mainArea=Borders&mainText=&mainTextExplicitMatch=null&compLevel=CountryProfile&compText=&compTextExplicitMatch=null
11. Moore JE, Kruijshaar ME, Ormerod LP. Increasing reports of nontuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006. BMC Public Health 2010; 10:612. http://dx.doi.org/10.1186/1471-2458-10-612
12. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol 2007; 211:144-156. http://dx.doi.org/10.1002/path.2104
13. Ahn CH, Lowell JR, Onstad GD et al. A demographic study of disease due to Mycobacterium kansasii or M. intracellulare-avium in Texas. Chest 1979; 75:120-125. http://dx.doi.org/10.1378/chest.75.2.120
14. Fogan L. PPD antigens and the diagnosis of mycobacterial disease. Arch Intern Med 1969; 124:49-54. http://dx.doi.org/10.1001/archinte.124.1.49
15. Trnka L, Danková D, Svandová E. Six years' experience with the discontinuation of BCG vaccination: 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tuber Lung Dis 1994; 75:348-352. http://dx.doi.org/10.1016/0962-8479(94)90080-9
16. Romanus V, Hallander HO, Wåhlén P, et al. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. Tuber Lung Dis 1995; 76:300-310. http://dx.doi.org/10.1016/S0962-8479(05)80028-0
17. Raviglione M. Diseases due to other mycobacteria. In: Heymann D, editor. Control of communicable diseases manual. Washington: American Public Health Association; 2004. p.572-573.
18. Henriques B, Hoffner SE, Petrini B et al. Infection of Mycobacterium malmoense in Sweden: Report of 221 cases. Clin Infect Dis 1994; 18:596-600. http://dx.doi.org/10.1093/clinids/18.4.596
19. Henry MT, Inamdar L, O'Riordain D et al. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 2004; 23:741-746. http://dx.doi.org/10.1183/09031936.04.00114004
20. Lamden K, Watson J, Knerer G et al. Opportunist mycobacteria in England and Wales 1982-1994. Commun Dis Rep CDR Review 1996; 6:147-151.
21. McGarvey J, Bermudez LE. Pathogenesis of nontuberculous mycobacterial infections. Clin Chest Med 2002; 23:569-583. http://dx.doi.org/10.1016/S0272-5231(02)00012-6
22. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis 1987; 135:1007-1014.
23. Prince DS, Peterson DD, Steiner RM et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321:863-868. http://dx.doi.org/10.1056/NEJM198909283211304
24. van Ingen J, Hoefsloot W, Dekhuijzen PN et al. The changing pattern of clinical Mycobacterium avium isolation in the Netherlands. Int J Tuberc Lung Dis 2010;14: 1176-1180.
25. van Ingen J, Bendien SA, de Lange WC et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 2009; 64:502-506. http://dx.doi.org/10.1136/thx.2008.110957
26. Ching, Y. Assessment of management and response to treatment of nontuberculous mycobacteria infection. Unpublished data 2007.
27. Böllert FGE, Watt B, Greening AP et al. Non-tuberculous pulmonary infections in Scotland: a cluster in Lothian? Thorax 1995; 50:188-190. http://dx.doi.org/10.1136/thx.50.2.188
28. Thomsen VO, Andersen AB, Miörner H. Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey. Scand J Infect Dis 2002; 34:648-653. http://dx.doi.org/10.1080/00365540210147813
29. Banks J, Jenkins PA. Combined versus single antituberculous drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. Thorax 1987; 42:838-842. http://dx.doi.org/10.1136/thx.42.11.838
30. Koh WJ, Kwon OJ, Jeon K. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006; 129:341-348. http://dx.doi.org/10.1378/chest.129.2.341
31. Heifets LB. Synergistic effect of rifampicin, streptomycin, ethionamide and ethambutol on Mycobacterium intracellulare. Am Rev Respir Dis 1982; 125:43-48.
32. Swenson JM, Thornsberry C, Silcox VA. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother 1982; 22:186-192.
33. Research Committee of the British Thoracic Society. First randomised controlled trial of treatments for pulmonary disease caused by M. avium intracellulare, M. malmoense and M. xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 2001; 56:167-172. http://dx.doi.org/10.1136/thorax.56.3.167